We are live on
!
Find out more
MRCM
M&R Capital Management Portfolio holdings
AUM
$454M
1-Year Est. Return
40.11%
This Fund
S&P 500
This Quarter
Est. Return
+8.2%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$364M
AUM Growth
+$9.44M
(+2.7%)
Cap. Flow
-$14M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
42.64%
Holding
624
New
166
Increased
90
Reduced
129
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$325K |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$158K |
| 3 |
Invesco QQQ Trust
QQQ
|
+$151K |
| 4 |
Eli Lilly
LLY
|
+$144K |
| 5 |
Chevron
CVX
|
+$118K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Petco
WOOF
|
+$1.83M |
| 2 |
FedEx
FDX
|
+$1.64M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$1.51M |
| 4 |
Walt Disney
DIS
|
+$1.17M |
| 5 |
Warner Bros
WBD
|
+$1.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.47% |
| 2 | Technology | 19.27% |
| 3 | Healthcare | 15.16% |
| 4 | Communication Services | 10.94% |
| 5 | Consumer Discretionary | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Coca-Cola
KO
$386B
| $3.51M | 0.97% |
55,237
+147
| +0.3% | +$8.87K |
|
27
Comcast
CMCSA
$96B
| $3.44M | 0.95% |
98,449
-7,245
| -7% | -$240K |
|
28
Fox Class A
FOXA
$28.8B
| $3.21M | 0.88% |
105,754
-13,746
| -12% | -$419K |
|
29
ExxonMobil
XOM
$644B
| $3.13M | 0.86% |
28,416
+296
| +1% | +$31.7K |
|
30
Costco
COST
$419B
| $3.13M | 0.86% |
6,863
+121
| +2% | +$59.1K |
|
31
UnitedHealth
UNH
$353B
| $2.9M | 0.8% |
5,464
+3
| +0.1% | +$1.59K |
|
|
32
FedEx
FDX
$78.3B
| $2.9M | 0.8% |
16,723
-9,874
| -37% | -$1.64M |
|
33
Union Pacific
UNP
$183B
| $2.82M | 0.78% |
13,630
-75
| -0.5% | -$15.4K |
|
34
Abbott
ABT
$195B
| $2.77M | 0.76% |
25,264
-299
| -1% | -$31K |
|
35
Toronto Dominion Bank
TD
$199B
| $2.63M | 0.72% |
40,655
-962
| -2% | -$62.1K |
|
36
Home Depot
HD
$329B
| $2.62M | 0.72% |
8,294
-241
| -3% | -$73.4K |
|
37
AbbVie
ABBV
$451B
| $2.61M | 0.72% |
16,127
-413
| -2% | -$63.3K |
|
38
CSX Corp
CSX
$95B
| $2.56M | 0.7% |
82,559
-1,797
| -2% | -$54K |
|
39
Danaher
DHR
$152B
| $2.38M | 0.65% |
10,117
+59
| +0.6% | +$13.7K |
|
40
Pfizer
PFE
$159B
| $2.33M | 0.64% |
45,439
-313
| -0.7% | -$15K |
|
41
iShares Biotechnology ETF
IBB
$10.5B
| $2.25M | 0.62% |
17,151
-219
| -1% | -$28.3K |
|
42
Procter & Gamble
PG
$334B
| $2.2M | 0.6% |
14,499
-425
| -3% | -$59.6K |
|
43
Colgate-Palmolive
CL
$72.3B
| $2M | 0.55% |
25,376
-497
| -2% | -$37.3K |
|
44
Berkshire Hathaway Class A
BRK.A
$1.08T
| $1.87M | 0.52% |
4
| – | – |
|
|
LSXMK
45
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $1.85M | 0.51% |
60,920
+16
| +0% | +$512 |
|
46
NextEra Energy
NEE
$171B
| $1.75M | 0.48% |
20,934
+75
| +0.4% | +$6.06K |
|
47
Canadian Pacific Kansas City
CP
$82.7B
| $1.7M | 0.47% |
22,792
-750
| -3% | -$56.4K |
|
|
SNV
48
DELISTED
Synovus
SNV
| $1.39M | 0.38% |
36,950
-1,169
| -3% | -$46.4K |
|
|
49
Warner Bros
WBD
$72.1B
| $1.37M | 0.38% |
144,789
-95,447
| -40% | -$1.08M |
|
|
50
Chevron
CVX
$396B
| $1.36M | 0.37% |
7,580
+674
| +10% | +$118K |
|
Similar funds
EDRIA
SFP
AC
NIC
WCA
KC
SIGI
FPFS
M&R Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, M&R Capital Management held 624 positions worth $364M, up 2.7% from $354M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
M&R Capital Management withdrew a net $14M in Q4 2022, closing 20 positions and reducing 129 holdings. Its most notable exit was iShares Core S&P Total US Stock Market ETF, an estimated $160K position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
Against the trend, M&R Capital Management opened a new position in Invesco QQQ Trust worth $145K.
- M&R Capital Management's largest Q4 2022 buy was Invesco QQQ Trust: 545 shares worth $145K.
- M&R Capital Management added most to Bristol-Myers Squibb in Q4 2022, an estimated $325K increase.
- M&R Capital Management's biggest Q4 2022 reduction was Petco, cutting an estimated $1.83M.
- M&R Capital Management fully exited iShares Core S&P Total US Stock Market ETF in Q4 2022, selling an estimated $160K.
- M&R Capital Management's ten largest holdings make up 43% of its $364M portfolio in Q4 2022.
- M&R Capital Management opened 166 new positions and closed 20 in Q4 2022.
- M&R Capital Management's portfolio value rose 2.7% quarter-over-quarter to $364M.
Based on M&R Capital Management's 13F filing for Q4 2022, filed 11 Jan 2023.